Recombinant Anti-CD19 x Anti-CD3 Bispecific Antibody (IgG-scFv)
TypeName: Business Offer
Category:
Offer Date:2019/03/05
Country: United States
Summary: Recombinant Anti-CD19 x Anti-CD3 Bispecific Antibody (IgG-scFv) is designed to be expressed as a LC and an extended HC with scFv moiety linked to the C terminus. It is a symmetric bispecific and tetravalent molecule, bivalent for each antigen specificity, 2+2 antigen-binding valency. This BsAb can retarget T cells to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Leukemia therapy.https://www.creative-biolabs.com/bsab/symbolsearch-cd19%2520%2526%2520cd3.htm
Agriculture & Food
Business Services
Electronics, IT and Telecoms
Leisure & Tourism
Minerals
Textiles, Clothing, Leather,
Transport & Logistics
